87586 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 

Background and Brief Description 

Oropouche virus is an emerging virus 

in the Americas that is spread by the 

bite of midges and some species of 

mosquitoes. Infection with Oropouche 

virus generally causes a febrile illness, 

but more severe disease such as 

meningitis and hemorrhagic disease can 

occur. Beginning in late 2023, the 

geographic range of Oropouche virus 

has expanded, with over 10,000 cases 

from six countries reported in 2024 as 

of October 15. The first U.S. cases were 

reported in the summer of 2024, all 

among returning international travelers. 

This recent geographic expansion, along 

with reports of deaths among cases, 

vertical transmission leading to fetal 

loss and birth defects, and identification 

of live virus in semen raise concerns 

about the broader threat this virus 

represents to the United States. There 

are numerous gaps in our understanding 

of this emerging virus, including the 

urgent need to evaluate the possibility 

of sexual transmission to inform 

prevention recommendations, especially 

for pregnant people and their partners, 

or those considering pregnancy. 

The purpose of this investigation is to 

better define the risk factors, clinical 

course, viral shedding, and potential for 

sexual transmission among patients 

with Oropouche virus disease. 

Participants will be interviewed about 

their symptoms, medical and travel 

history, potential risk factors for 

infection, and sexual partners since 

becoming ill. They will be followed over 

time to see if their symptoms reoccur, 

which has been highlighted as a unique 

feature of Oropouche virus disease 

among similar viruses. They will also 

submit specimens of various bodily 

fluids over a 12-week period to be tested 

for Oropouche virus RNA. Lastly, sexual 

contacts of people who have been 

diagnosed with Oropouche virus disease 

will be interviewed to see if they 

experienced any symptoms consistent 

with Oropouche virus disease after 

these sexual encounters. Sexual contacts 

that report symptoms will be asked to 

have a blood sample collected and 

tested for evidence of Oropouche virus 

infection. 

The findings of this investigation will 

inform prevention guidance, improve 

clinical recognition and diagnosis, and 

prevent further illnesses of Oropouche 

virus disease. Preliminary results will 

be used immediately to inform agency 

response activities and prevention 

guidance to help people protect 

themselves from Oropouche virus 

disease. CDC requests Emergency OMB 

approval for an estimated 663 annual 

burden hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

General public ..................................... Baseline survey .................................. 200 1 30/60 100 

Follow-up clinical survey .................... 200 6 15/60 300 

Symptom Diary ................................... 200 6 10/60 200 

Contact tracing survey ....................... 100 1 15/60 25 

Sexual contact interview form ............ 150 1 15/60 38 

Total ............................................. ............................................................. ...................... .......................... .................... 663 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–25553 Filed 11–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–0891; Docket No. CDC–2024– 

0086] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled World Trade Center (WTC) Health 

Program Enrollment, Appeals & 

Reimbursement. The WTC Health 

Program is a Federal limited benefit 

health care program providing medical 

monitoring and treatment benefits to 

eligible firefighters and related 

personnel, law enforcement officers, 

and rescue, recovery, and cleanup 

workers who responded to the 

September 11, 2001, attacks in New 

York City, at the Pentagon, and in 

Shanksville, Pennsylvania (responders), 

and to eligible persons who were 

present in the dust or dust cloud on 

September 11, 2001, or who worked, 

resided, or attended school, childcare, 

or adult daycare in the New York City 

disaster area (survivors). 

DATES: CDC must receive written 

comments on or before January 3, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0086 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments through 

the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 87587 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Under the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3501–3520), 

Federal agencies must obtain approval 

from the Office of Management and 

Budget (OMB) for each collection of 

information they conduct or sponsor. In 

addition, the PRA also requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each new proposed 

collection, each proposed extension of 

existing collection of information, and 

each reinstatement of previously 

approved information collection before 

submitting the collection to the OMB for 

approval. To comply with this 

requirement, we are publishing this 

notice of a proposed data collection as 

described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

World Trade Center Health Program 

Enrollment, Appeals & Reimbursement 

(OMB Control No. 0920–0891, Exp. 09/ 

30/2025)—Revision—National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Institute for 

Occupational Safety and Health 

(NIOSH) seeks OMB approval for a 

Revision of an ongoing information 

collection titled World Trade Center 

Health Program Enrollment, Appeals & 

Reimbursement (OMB Control No. 

0920–0891). In accordance with the 

James Zadroga 9/11 Health and 

Compensation Act of 2010, individuals 

newly seeking enrollment in the World 

Trade Center (WTC) Health Program as 

responders or survivors may apply to 

the Program. The recently passed 

National Defense Authorization Act for 

Fiscal Year 2024 (NDAA) expands 

Program enrollment eligibility for 

Pentagon and Shanksville responders. 

title I of the Zadroga Act (Pub. L. 111– 

347, as amended by Pub. L. 114–113 

and Pub. L. 116–59), added title XXXIII 

to the Public Health Service Act (PHS 

Act), establishing the World Trade 

Center (WTC) Health Program within 

the Department of Health and Human 

Services (HHS). The Director of NIOSH 

serves as the Administrator of the WTC 

Health Program for most purposes, with 

certain payment functions carried out 

by the Centers for Medicare & Medicaid 

Services. As established by the Zadroga 

Act, the WTC Health Program is a 

Federal limited benefit health care 

program providing medical monitoring 

and treatment benefits to eligible 

firefighters and related personnel, law 

enforcement officers, and rescue, 

recovery, and cleanup workers who 

responded to the September 11, 2001, 

attacks in New York City, at the 

Pentagon, and in Shanksville, 

Pennsylvania (responders), and to 

eligible persons who were present in the 

dust or dust cloud on September 11, 

2001, or who worked, resided, or 

attended school, childcare, or adult 

daycare in the New York City disaster 

area (survivors). The WTC Health 

Program has been authorized for 75 

years (through 2090). 

Respondents are WTC Health Program 

members and potential members. In this 

Revision, NIOSH requests OMB 

approval of the revised WTC Health 

Program Pentagon/Shanksville 

Application for Enrollment, to include 

language regarding the expanded 

eligibility criteria mandated by the 

National Defense Authorization Act 

(NDAA) for Fiscal Year 2024. NIOSH 

also requests OMB approval of a new 

web-based Youth Research Cohort 

(YRC) Registration portal that will be 

used to engage future cohort members 

and allow them to self-enroll into the 

YRC. 

In this Revision, total annualized 

burden will increase from 12,882 hours 

to 16,132 (+3,250 hours). The greatest 

increase in burden (+3,000 hours) is the 

result of the new secure, public-facing 

web-based portal for the YRC. In 

December 2022, the Consolidated 

Appropriations Act, 2023 (Pub. L. 117– 

328), amended section 3341 of the PHS 

Act to direct the Administrator to 

establish a new cohort for future 

research. This portal has been 

developed to engage with future cohort 

members and streamline the enrollment 

process into the YRC. This web-based 

portal will maintain the privacy and 

data protection of future cohort 

members in accordance with the 

provisions of the Health Insurance 

Portability and Accountability Act of 

1996 (HIPAA) and HIPAA regulations. 

Another increase in annualized 

burden (+250 hours) is due to the 

expanded eligibility for Program 

membership for Pentagon and 

Shanksville responders, as mandated in 

the NDAA. The WTC Health Program 

Pentagon/Shanksville Application for 

Enrollment has been updated to reflect 

the new eligibility criteria mandated by 

the NDAA. The revised application now 

includes an additional eligibility 

question targeting specific groups such 

as active duty, retired, or reserve 

members of the military, civilian 

employees of the Department of Defense 

(DOD), or certain DOD contractors who 

responded to the Pentagon or 

Shanksville sites. The application also 

now clarifies that in addition to the 

work status, the responder must have 

participated in rescue, recovery, 

demolition, debris cleanup, or other 

related services to be eligible to enroll 

in the Program. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

FDNY Responder ...... World Trade Center Health Program FDNY 

Responder Application for Enrollment.

140 1 30/60 ......................... 70 


lotter on DSK11XQN23PROD with NOTICES1
87588 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

General Responder ... World Trade Center Health Program Responder Application for Enrollment (Other 

than FDNY).

6,215 1 30/60 ......................... 3,108 

Pentagon/Shanksville 

Responder.

World Trade Center Health Program Pentagon/Shanksville Responder Application 

for Enrollment.

742 1 30/60 ......................... 371 

WTC Survivor ............ World Trade Center Health Program Survivor Application for Enrollment (all languages).9,240 1 30/60 ......................... 4,620 

General responder .... Clinic Selection Postcard for new general 

responders in NY/NJ to select a clinic.

3,830 1 15/60 ......................... 958 

Interested Party ......... Petition for the addition of health conditions 35 1 1 ................................ 35 

Program Applicants or 

Members.

Designated Representative Appointment 

Form.

1,300 1 15/60 ......................... 325 

Program Applicants or 

Members.

Designated Representative HIPAA Release 

Form.

1,300 1 15/60 ......................... 325 

Program Members ..... Member Satisfaction Survey ........................ 6,600 1 30/60 ......................... 3,300 

General Public ........... WTC Health Program HIPAA Authorization 

for Deceased Individuals.

30 1 15/60 ......................... 8 

Program Applicants or 

Members.

WTC Health Program General HIPAA Authorization to Third Parties.30 1 15/60 ......................... 8 

Program Applicants or 

Members.

Designated Representative Appointment 

Form.

15 1 15/60 ......................... 4 

Youth Research Cohort Enrollees.Youth Research Cohort Registration Portal 6,000 1 30/60 ......................... 3,000 

Total ................... ....................................................................... ........................ ........................ ................................... 16,132 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–25556 Filed 11–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–0607; Docket No. CDC–2024– 

0089] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled The National 

Violent Death Reporting System. 

(NVDRS). NVDRS is a state-based 

surveillance system developed to 

monitor the occurrence of violent 

deaths, including homicide, suicide, 

deaths due to legal intervention, deaths 

of undetermined intent, and 

unintentional firearm deaths in the U.S. 

DATES: CDC must receive written 

comments on or before January 3, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0089 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments through 

the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 


lotter on DSK11XQN23PROD with NOTICES1